Drug therapy for people hospitalized with the COVID-19 virus may soon be on the horizon. According to a press release from Health and Human Services (HHS), “the Food and Drug Administration (FDA) issued an Emergency Use Authorization….to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.”
Thirty million doses of the hydroxychloroquine sulfate were donated by drug maker Sandoz while Bayer Pharmaceuticals donated one million doses of chloroquine phosphate.
